When men lose their edge, they lose more than performance — they lose themselves. D1CK DAO is fighting back with real science. Over 300 million men worldwide suffer from erectile dysfunction, one in three experience premature ejaculation, and mean Testosterone level have dropped more than 20% since 2000s — yet real solutions remain rare, and stigma remains high. Our vision is to build a decentralized community where scientists and men work together to solve the real, often-ignored problems men face, not just the profitable ones. We believe men deserve more than quick fixes. They deserve real solutions, real science, and a future they can stand proud in — both inside and out.
Erectile dysfunction (ED) affects approximately 300 million men worldwide
Men’s sexual health supplement market projected to exceed $6 billion by 2030
Direct funding for male sexual health research represents less than 1% of NIH’s overall annual research budget.
There is no dedicated Office for Men’s Health at NIH. No targeted funding. Yet over 300 million men continue to struggle in silence. It’s time to address what the system has long ignored.
Men’s sexual health is a critical yet deeply underserved field. Over 300 million men globally suffer from erectile dysfunction, one in three experience premature ejaculation, and up to 40% face low testosterone, issues that impact not only physical h...
We are developing a next-generation, multi-targeted supplement formulation to enhance erectile function, optimize hormonal balance, and promote holistic male sexual wellness. Built on clinically validated bioactive compounds, this project aims to shift the standard from superficial fixes to science-backed, measurable outcomes.
This trial pioneers a comprehensive evaluation of testosterone delivery methods — oral, transdermal (gel), and hybrid systems — assessing their bioavailability, clinical efficacy, patient adherence, and safety. Today, most testosterone replacement therapies rely on injectable forms, which are often painful, invasive, and associated with significant side effects and poor long-term compliance. TRIAXIS seeks to define safer, more effective, and patient-friendly alternatives to restore hormonal health with precision and sustainability.
Exploring the critical connection between hormonal support and cognitive vitality. By clinically evaluating a natural testosterone-booster’s impact on memory, executive function, mood, and stress resilience, this trial aims to establish a new frontier where enhancing hormonal health translates into measurable cognitive performance.
We're the first BioDAO turning real-world profits into $D1CK buybacks — because ownership should grow with impact....
by James L. Nuzzo
NIH
NIH